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1. Introduction 
 
Science and technology play an indisputable role in a country’s development. The 
increase in R&D investment in countries such as Spain when crisis strikes, as it has 
now, is essential to ongoing social and economic progress. 
Knowledge transfer and fluent relations among the actors involved in scientific and 
technological development are the keys to improving system performance. In this 
regard, an increasing number of studies have analyzed the relationships between the 
universities and research centres that generate knowledge on the one hand, and private 
enterprise that transforms knowledge into goods usable by society on the other. 
A variety of indicators help measure such collaboration: co-authorship of scientific 
papers, joint participation in patents, shared research agreements, hiring of university 
graduates by private enterprise and practising professionals’ participation in formal 
education, to name a few. Nonetheless, the availability of such information is limited or 
even non-existent in some respects, and where it does exist, the aggregates tend to be 
scantly comparable (Tijssen RJW et al., 2009). 
Prior research relating to the present study has focused on the analysis of enterprise 
involvement in the Research and Development (R&D) system. Many papers have 
analyzed the relationships among universities, industry and government agencies, the 
so-called triple helix metaphor (Etzkowitz H and Leydesdorff L, 1997). Some focus on 
the study of the structures, cultures, routines and characteristics of the various types of 
institutions based on scientific publications, a method widely used in international 
comparisons, in which the contribution to an understanding of economic development is 
defined to be a product (Calvert J and Patel P, 2003), (Howard J, 2005), (Leydesdorff L, 
2003), (Leydesdorff L and Meyer M, 2006). Others address the implications of the 
metaphor in the context of regional policy (Danell R and Persson O, 2003), (Jaffe AB, 
1989), (Jaffe AB, 1993) and technological progress published in reputed journals (Narin 
F et al., 1997). Yet others assume that knowledge and learning lie at the core of 
innovative systems and are the new lead players in the economy and society (Etzkowitz 
H and Leydesdorff L, 2000), (Lundvall BA, 1995). Some authors concentrate on the 
motivation underlying collaboration (Mora Valentín EM, 2002), the use of 
scientometric indicators to analyze collaboration (Leydesdorff L et al., 2006) or the 
importance of collaboration as a paradigm for moving from to linear to interactive 
models for innovation (Muñoz E, 2001). Bibliometric indicators are likewise used to 
analyze regional differences in scientific and technological development (Gómez I et 
al., 2005). Even the effect of public R&D policies on national (Schilling P, 2005) or 
regional (Braczyk HJ et al., 2003), (Cooke P et al., 1997), (Cooke P and Memedovic O, 
2003), (Sanz Menéndez L et al., 2001) scientific and technological output has been 
analyzed. 
All these studies analyze the measures adopted or that should be adopted to improve 
the transfer of scientific and technological findings from public institutions to industry. 
Most of these papers focus on the triple relationship (university-industry-government), 
either with a detailed description of the relevant role of universities or the effect of 
public policies on science funding. Despite the growing interest, however, few attempts 
have been made to gather data with which to analyze the nature and scope of 
collaboration with a focus on private enterprise. 
This article makes a quadruple contribution to the analysis of the role of R&D 
collaboration by businesses based on the co-authorship of scientific papers. First, it 
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analyzes private enterprise participation in research by specialities. Second, it examines 
the geographic distribution of national and international collaboration. Third, it studies 
the mechanisms for collaboration with other sectors involved in research. Fourth, it 
undertakes a structural analysis of the relationships generated by the companies 
analyzed. This endeavour involved an in-depth analysis of the data on the 50 
predominant Spanish companies in terms of scientific output. 
The paper is organized as follows: section 2 describes the issues addressed in this 
study. Section 3 reviews the methodology used. Section 4 reports the findings. Section 5 
discusses the results and their scope. Section 6 summarizes the highlights of the study 
and their possible implications for both private enterprise and research policies. 
 
2. Research questions 
 
This paper aims to answer a number of questions about companies' involvement in 
the development of Spanish research: What is their present role in the scientific 
scenario? Where are the major producers located? Which scientific specialities are the 
most productive? Who are their main partners? What is their position on the resulting 
co-authorship networks? Fortunately, all the issues and characteristics explored in this 
study can be addressed with the information available in publicly accessible scientific 
publications, as explained below. 
 
3. Methods 
 
The data source used was the Web of Science (WoS, 2008), a Thomson Reuters 
product that includes the following databases: 1) Science Citation Index Expanded 
(SCI- Expanded), specializing in science and medicine, 2) Social Science Citation Index 
(SSCI), specializing in social science and, 3) Arts and Humanities Citation Index 
(AHCI). Access to the WoS was cost-free thanks to the public service provided by 
Spain’s Ministry of Science and Innovation for Spanish researchers, through the 
Fundación Española para la Ciencia y la Tecnología (FECYT, Spanish foundation for 
science and technology). 
As noted, bibliometric analyses do not measure all types of publications. Indicators 
are usually based on data in the Thomson Reuters databases, which are regarded to be 
representative of peer-reviewed, publicly accessible papers with high international 
visibility and impact. The Thomson Reuters databases feature a series of advantages 
that make them indispensable for bibliometric studies, particularly for studies on 
scientific collaboration. The choice of this particular source to obtain relevant 
bibliographic data from which to calculate the indicators used in this study was based 
on a number of considerations. 
The first has to do with multi-disciplinarity and the match between the subject 
matters in these bases and commercial products. The idea was to obtain information on 
scientific disciplines and a number of geographic domains. This called for wide and 
uniform disciplinary coverage to ensure that the comparisons would be as evenly 
balanced as possible. In this regard, the WoS databases, with multi-disciplinary sources 
and broad coverage, are ideal for this purpose. 
Nonetheless, in certain scientific domains and countries, journal publication is not 
the sole vehicle for disseminating production. In social science and humanities, for 
instance, monographs are the instrument most prevalently used. Similarly, in 
engineering and technological disciplines, technical reports, an important and frequently 
the preferred medium, are not always converted into scientific papers. As a result, the 
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impact of monographs differs widely from the impact obtained by scientific articles 
(Hicks D, 2004). Furthermore, in the case of social science and humanities production 
in Spain, the preferred channel tends to be national journals rather than international 
journals with established impact factors (Gómez I et al., 2004). Added to the 
predominance of a local focus in such literature, such limitations preclude the exclusive 
use of the above databases for assessing and comparing domestic output in these subject 
areas to production in experimental and biomedical science, for instance, which is better 
represented in WoS bases (Archambault E and Gagné EV, 2004), (Moed HF, 2005). 
Although over the years the these bases have been criticized for what has been 
regarded to be limited coverage of disciplines, languages and countries (Andersen H, 
2000), more recent studies have concluded that with the exception of Germany in 
agriculture and France as a science publisher, journal coverage in the SCI and the 
Journal of Citation Reports (JCR) is well balanced with respect to the journals listed in 
Ulrich’s Science & Technology, the most complete database of journal titles, with over 
220 000 listed in 1998 (Braun T et al., 2000). As a general rule, the chief scientific 
periodical publishers are over-represented both in the SCI and the JCR, along with 
English language social science and humanities journals, but neither of these drawbacks 
affects the objectives of the present study. 
A second advantage to this type of tools is their structure, which distinguishes them 
from other similar databases. Their added value lies in the importance attached to the 
information on the institutional affiliation of all the authors of a given paper. This 
information can be used for detailed analyses of scientific collaboration. 
A third reason justifying the choice of these sources is that they contain all the 
bibliographic references given in the articles listed. With this information, a basis can be 
established for calculating essential bibliometric indicators, relating, for instance, to 
collaboration and the impact of scientific literature. 
Moreover, supplementary information on journals was retrieved from the JCR (JCR, 
2007). This database includes information on journals in the WoS and their visibility 
indicators, such as the well known impact factor. 
Lastly, the information used to classify companies by size and specific business 
profile was drawn from the Sistema Anual de Balances Ibéricos (SABI, yearly Iberian 
balance sheet system), which contains financial information on Spanish and Portuguese 
companies since 1990. 
 
3.1. Data 
 
Records for the period 1995-2005, inclusive, were retrieved from the above 
databases. The initial search criterion was all articles in which Spain appeared in the 
address field. The initial search results yielded a total of 298 962 papers of all kinds 
published by Spanish authors. The address field was subsequently standardized to 
reliably determine the institution, sector and region for each bibliographic record. The 
sub-set of papers attributable to private enterprise contained a total of 7 702 elements. 
These data were used to create a relational database. The information contained in 
the JCR on each journal was added, namely: bibliographic identification, number of 
papers published by year, subject category and impact index by year. 
 
3.2. Data Standardization 
 
Several fields in the database had to be standardized, in particular both authors’ and 
institutional names, to suitably analyze and mine the data. The address field usually 
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comprises four levels: main organization, department within the organization, city and 
country. In many cases, only three levels are listed, excluding the department or 
institutional level. The country is generally highly standardized and the city can be 
standardized using postal codes. Many variations can be found at all these levels, 
however. This is one of the problems that had to be solved, for it could have directly 
affected the relationships generated among the institutions producing scientific 
information. The procedure followed involved locating the variations in each 
institution’s name, choosing an acceptable denomination that encompassed them all, 
and attributing it to the respective region semi-automatically. 
 
3.3. Indicators 
 
Three types of indicators were used: 
Bibliometric indicators: Ndoc is the total number of papers. Ndoc col is the total 
number of co-authored papers. Citations is the total number of times all the papers were 
cited. The normalized impact factor (NIF) normalizes the expected impact by retaining 
the variability, but smoothing the scale of ISI categories  (Olmeda Gómez C et al., 
2009). Research power (RP) weights the expected visibility by the number of papers 
authored by the institution analyzed, and is defined as the summation of the product of 
output times the NIF. The internationalization index gives the percentage of papers 
written in collaboration with non-Spanish partners with respect to the total published. 
Structural indicators: degree is the total number of institutions directly related to the 
actor analyzed. Betweenness is the frequency with which a node appears on a geodesic 
connecting two other nodes (Mrvar A, 2000). The clustering coefficient (CC) reflects 
local density in the vicinity around the node analyzed (Batagelj V and Mrvar A, 2004), 
(Nooy W et al., 2005). 
Hybrid indicators: the popularity Index provides a measure that weights the number 
of papers (popularity) by the cohesion of each node’s collaboration pattern. The prestige 
index adjusts the number of citations (prestige) for the degree of cohesion of each 
author’s collaboration pattern. Such hybrid indicators embody a new approach to 
research, placing the necessary weight on the degree of collaboration among 
researchers, which has been ignored to date, despite its vital importance for science and 
technology policy managers (Perianes-Rodríguez A et al., 2009). 
 
4. Results 
 
4.1. Specialities 
 
In absolute numbers, a total of 1 381 Spanish companies engaged in national 
scientific production in the period studied, which together produced only 2,58 % of the 
country’s total output with international visibility. 
As noted, this study reviews a number of aspects of scientific collaboration as 
practised by the 50 most productive companies conducting business in Spain. 
The first such aspect refers to the specialization of their research. Figure 1 graphs 
scientific output by these companies and private enterprise in general between 1995 and 
2005. The curves for both were characterized by a steady and nearly parallel rise. 
 
Figure 1. Scientific output by Spanish private enterprise as a whole and the top 50 firms, 
1995-2005 
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The similarity in the two patterns is surely related to the fact that the top 50 
companies (3,62 % of the total number) account for nearly 50 % of the co-authored 
papers produced by the private sector (3 842 papers). 
Table 1 gives the absolute data on top 50 company production by speciality. 
Speciality definitions were based on the JCR subject categories into which the 
publishing journals are classed. These categories were subsequently grouped into the 26 
major divisions of scientific knowledge defined  by Spain’s National Assessment and 
Prospective Studies Agency (ANEP, 2009). 
 
Table 1. Scientific output by the top 50 Spanish firms, 1995-2005 
 
Organization &doc Main class % Main class Specialty 
Prous Science 323 323 100 Physiology and pharmacology 
Glaxo SmithKline 312 178 57.05 Molecular biology 
PharmaMar 288 176 61.11 Medicine 
Lilly 279 143 51.25 Medicine 
Almirall 254 143 56.30 Medicine 
Merck Sharp Dohme 160 57 35.63 Medicine 
REPSOL 155 88 56.77 Materials science 
Pfizer 147 134 91.16 Medicine 
ALK Abello 113 108 95.58 Medicine 
Leti Laboratories 103 96 93.20 Molecular biology 
Uriach 95 41 43.16 Physiology and pharmacology 
Ferrer Group 93 55 59.14 Physiology and pharmacology 
Esteve 91 52 57.14 Physiology and pharmacology 
Menarini 72 40 55.56 Physiology and pharmacology 
Bayer 58 52 89.66 Medicine 
Telefonica 54 23 42.59 Electronic technology 
Mar&Gen 53 51 96.23 Medicine 
Novartis 53 45 84.91 Medicine 
Aventis 52 50 96.15 Medicine 
Ingenasa 49 42 85.71 Molecular biology 
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Carburos Metalicos 44 33 75 Chemistry 
Merck Farma 42 28 66.67 Medicine 
Abbott Laboratories 41 31 75.61 Medicine 
FAES Farma 41 24 58.54 Physiology and pharmacology 
Tamag Iberica 41 38 92.68 Physics 
PULEVA 40 25 62.50 Food science and technology 
INESCOP 40 30 75 Materials science 
Cantabria Pharmac Industries 39 25 64.10 Medicine 
Biomar Institute 39 26 66.67 Physiology and pharmacology 
Bristol Myers Squibb 39 35 89.74 Medicine 
ARCELOR 39 24 61.54 Chemical engineering 
ANFACO 39 27 69.23 Molecular biology 
Knoll 37 21 56.76 Medicine 
Abbott Nutrition 36 27 75 Medicine 
Labein 36 13 36.11 Computer science 
AstraZeneca 35 34 97.14 Medicine 
Alcatel 35 34 97.14 Electrical engineering 
Schering Plough 34 28 82.35 Medicine 
Antibioticos 33 31 93.94 Molecular biology 
Pharma Res 32 31 96.88 Medicine 
Parke Davis 31 26 83.87 Medicine 
Iberdrola 31 12 38.71 Physics 
Sueno Lab 31 23 74.19 Medicine 
Biometric Technologies 30 25 83.33 Medicine 
Echevarne Laboratories 30 24 80 Medicine 
Vita Laboratories 30 15 50 Medicine 
INSA 29 24 82.76 Physics 
Ifidesa Aristegui 29 25 86.21 Medicine 
Janssen Cilag 27 24 88.89 Medicine 
ACERINOX 27 12 44.44 Chemical engineering 
 
 In the table, main class is defined to be the most productive area, listed in the final 
column. 
The data on top 50 specialization are aggregated in Table 2. Sixty eight per cent of 
the output dealt with some aspect of biomedicine. Other natural and experimental 
sciences together accounted for 22 %. By contrast, only slightly over 9 % of the papers 
dealt with technology and engineering. 
 
 Table 2. Top 50 company output by speciality 
 
Speciality % Institutions % &doc 
Medicine 11,11 30,32 
Physiology and pharmacology 10,59 20,31 
Molecular biology 10,08 15,22 
Chemistry 8,53 9,48 
Materials science 3,88 3,30 
Food science and technology 6,46 3,08 
Physics 4,91 2,72 
Livestock and fisheries 5,68 2,62 
Plant and animal biology 5,68 2,35 
Agriculture 5,68 2,26 
Electronics engineering 2,33 1,55 
Electrical engineering 2,58 1,52 
Chemical engineering 1,55 1,43 
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Computer science 4,13 1,02 
Earth science 3,36 0,82 
Psychology 4,13 0,72 
Civil engineering and architecture 3,36 0,58 
Mathematics 1,81 0,24 
Social science 1,81 0,19 
Aerospace, marine and mechanical engineering 1,29 0,17 
Philosophy 0,52 0,07 
Economics 0,52 0,03 
 
4.2. &ational collaboration. Geographic distribution 
 
The geographic distribution of the institutions participating in joint scientific 
production was also analyzed. The percentage of papers involving at least two national 
institutions came to 31,5 % of the total. Table 3 gives the geographic distribution of 
national collaboration among the top 50 firms. According to these data, institutions 
headquartered in the Community of Madrid participated in six of every ten papers. The 
second most active region was Catalonia, with 42 %. Nonetheless, joint research was 
conducted by more institutions headquartered in Catalonia (26,2 %) than in Madrid 
(25,9 %). 
 
Table 3. Geographic distribution of top 50 company collaboration 
 
Region % &doc %  Institutions 
Madrid 61,01 25,87 
Catalonia 42,32 26,16 
Andalusia 10,96 9,39 
Valencia 7,65 8,82 
Basque Country 7,00 4,77 
Castile and Leon 4,79 4,34 
Galicia 3,72 3,03 
Asturias 3,18 2,75 
Aragon 2,19 2,60 
Castile-La Mancha 1,69 3,18 
Navarre 1,67 1,59 
Canary Islands 1,43 1,45 
Cantabria 1,30 1,16 
Murcia 1,22 2,02 
Balearic Isles 0,75 1,01 
Extremadura 0,65 1,16 
La Rioja 0,29 0,72 
 
These data are supplemented by the information in Table 4, which gives the 
geographic distribution of the top 50 institutions only and their scientific output. The 
table shows that companies working out of Madrid accounted for a little over half of the 
top 50 output, followed by Catalonian firms with 33 %, while 44 % of such companies 
have their main office in Madrid (44 %) and 30 % in Catalonia. 
 
Table 4. Geographic distribution of top 50 companies 
 
Aut. Comm. % &doc % Institutions 
Madrid 54,26 44 
Catalonia 33,10 30 
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Andalusia 4,97 10 
Basque Country 2,75 6 
Castile and Leon 1,86 4 
Valencia 1,04 2 
Asturias 1,01 2 
Galicia 1,01 2 
 
4.3. International collaboration 
 
A third aspect analyzed was international collaboration among top 50 firms. Indeed, 
nearly one third (28,2 %) of the papers were co-authored with non-Spanish institutions. 
Table 5 shows the top ten partner countries by percentage of total joint studies and total 
international joint studies. 
 
Table 5. International collaboration Top ten countries 
 
Country % &doc Internationalization index 
USA 11,84 42,01 
England 4,50 15,97 
Italy 4,14 14,68 
France 4,06 14,40 
Netherlands 3,02 10,71 
Germany 2,19 7,76 
Belgium 0,96 3,42 
Switzerland 0,73 2,59 
Sweden 0,65 2,31 
Denmark 0,62 2,22 
 
Table 6 groups output by continents. Nearly 90 % of the international joint papers 
involved a European institution. Around one half of the international papers was co-
authored by institutions in the United States. 
 
Table 6. International collaboration by continent 
 
Continent Internationalization index 
Europe 89,20 
America 50,51 
Asia 2,12 
Oceania 1,66 
Africa 0,46 
 
4.4. Sectoral collaboration 
 
Another aspect studied was collaboration between the chief companies and other 
domestic sectors. In all, the top 50 network of institutional collaboration comprised 692 
organizations. Table 7 shows the percentage of institutions by sector and the percentage 
output for each. 
 
Table 7. Top 50 company collaboration by domestic sector 
 
Sector % Institutions % &doc 
Health System 59,39 29,93 
Private enterprise* 9,83 3,98 
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University 7,51 34,67 
National Res. Counc. 4,77 6,59 
Government 4,19 1,46 
Other sectors 3,47 1,56 
Univ-CSIC Centres 2,75 2,06 
Public institutes 0,87 0,68 
* Excluding the top 50 
 
Nearly 60 % of the institutions with which the top 50 firms partnered formed part of 
the health system, although the respective output accounted for just 30 % of all co-
authored papers. By contrast, while only 7,5 % of the participating institutions were 
universities, they co-authored 35 % of all joint studies. Conversely, the 10 % of private 
company partners (outside the top 50) produced barely 4 % of the total joint papers. 
 
4.5. &etwork analysis 
 
The last aspect analyzed was the position and prominence of top 50 companies in the 
institutional co-authorship network resulting from the preceding findings. Network 
analysis was used to obtain the structural indicators that supplement the bibliometric 
indicators. A suitable combination of the two types of indicators would provide a rough 
estimate of the prominence or importance of the organizations in the network. 
Table 8 gives the main bibliometric, structural and hybrid indicators for the top 50 
firms. As explained in the section on methodology, the first include number of papers, 
number of joint studies, number of citations, the normalized impact factor and the 
research power obtained for each institution. The second comprise degree, betweenness 
and the clustering coefficient. Finally, the popularity and prestige indexes are the result 
of combining bibliometric and structural indicators. 
 
Table 8. Bibliometric, structural and hybrid indicators. Top 50 
 
Organization &doc &doc col Citations &IF RP Degree Betweenness CC Popular-ity Prestige 
Prous Science 323 22 9 0,8 9,28 0,013 0,0005 0,0001 0,038 0,0011 
Glaxo SmithKline 312 229 400 1,2 204,6 0,2 0,0451 0,2031 63,353 81,2215 
PharmaMar 288 101 155 1,1 71,75 0,059 0,0126 0,0049 1,404 0,7555 
Lilly 279 165 211 1,1 105,8 0,224 0,07 0,2071 57,792 43,7063 
Almirall 254 136 211 1,1 100,9 0,177 0,0283 0,1759 44,672 37,1097 
Merck Sharp Dohme 160 65 79 1 44,76 0,198 0,0728 0,1873 29,964 14,7948 
REPSOL 155 115 189 1,1 104,2 0,049 0,0215 0,0016 0,244 0,2979 
Pfizer 147 139 60 1 43,64 0,165 0,0446 0,111 16,313 6,6586 
ALK Abello 113 85 154 1,2 69,63 0,101 0,0233 0,0318 3,592 4,8954 
Leti Laboratories 103 57 69 1,2 27,21 0,052 0,0093 0,0055 0,567 0,3800 
Uriach 95 47 65 1 38,19 0,045 0,0052 0,0044 0,414 0,2832 
Ferrer Group 93 54 64 1 44,71 0,071 0,0108 0,0109 1,018 0,7004 
Esteve 91 35 22 1,1 27,22 0,077 0,0145 0,0193 1,759 0,4253 
Menarini 72 44 54 1,1 33,66 0,071 0,0097 0,0155 1,118 0,8386 
Bayer 58 49 117 1,1 35,97 0,171 0,0243 0,2398 13,909 28,0576 
Telefonica 54 22 3 0,9 15,39 0,023 0,0086 0,0002 0,013 0,0007 
Novartis 53 35 82 1,2 21,85 0,113 0,0214 0,055 2,916 4,5122 
Mar&Gen 53 25 36 1,6 34,35 0,006 0,0001 0 0,001 0,0009 
Aventis 52 50 31 1,1 32,17 0,093 0,0087 0,0377 1,962 1,1696 
Ingenasa 49 19 36 1,2 20,85 0,019 0,0133 0,0002 0,009 0,0068 
Carburos Metalicos 44 44 99 1,3 52,63 0,012 0,0012 0,0001 0,005 0,0116 
Merck Farma 42 33 42 1,2 25,04 0,032 0,0028 0,0015 0,064 0,0638 
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Tamag Iberica 41 41 57 1 41,77 0,01 0 0,0002 0,009 0,0123 
Abbott Laboratories 41 36 57 1,1 38,4 0,012 0,0002 0,0001 0,002 0,0032 
FAES Farma 41 20 26 0,9 15,71 0,026 0,0033 0,0005 0,022 0,0141 
INESCOP 40 36 43 1 34,56 0,009 0,0002 0,0003 0,012 0,0132 
PULEVA 40 27 22 1 18,7 0,02 0,0038 0,0003 0,011 0,0062 
ARCELOR 39 36 9 1,1 29,32 0,017 0,0025 0,0002 0,007 0,0016 
Bristol Myers Squibb 39 34 66 1,1 18,1 0,09 0,0034 0,0375 1,464 2,4768 
ANFACO 39 34 58 1,2 36,35 0,007 0,0001 0 0,002 0,0028 
Cantabria Pharmac Indust 39 33 32 1 15,43 0,035 0,0039 0,0018 0,069 0,0570 
Biomar Institute 39 29 41 1 25,02 0,027 0,0017 0,001 0,040 0,0420 
Knoll 37 26 19 0,9 19,17 0,094 0,0318 0,0252 0,933 0,4792 
Abbott Nutrition 36 34 34 1,1 20,38 0,081 0,0065 0,0267 0,963 0,9091 
Labein 36 18 3 1,1 13,63 0,025 0,0091 0,0005 0,017 0,0014 
AstraZeneca 35 34 3 0,9 7,41 0,082 0,0053 0,024 0,841 0,0721 
Alcatel 35 11 5 1 9,14 0,009 0,0029 0 0,002 0,0002 
Schering Plough 34 30 14 1,1 11,83 0,075 0,0055 0,0229 0,779 0,3207 
Antibioticos 33 17 84 1,1 18,33 0,017 0,0012 0,0014 0,047 0,1207 
Pharma Res 32 30 52 0,9 11,8 0,039 0,0017 0,0031 0,100 0,1626 
Parke Davis 31 30 113 1,1 22,21 0,043 0,0018 0,004 0,124 0,4519 
Iberdrola 31 22 15 1,1 22,72 0,027 0,0066 0,0008 0,023 0,0113 
Sueno Lab 31 15 25 1,1 10,89 0,004 0 0 0,001 0,0005 
Biometric Technologies 30 30 5 1 9,02 0,072 0,0042 0,0143 0,430 0,0717 
Echevarne Laboratories 30 29 50 1,3 30,07 0,03 0,0042 0,0012 0,037 0,0611 
Vita Laboratories 30 28 82 1 16,71 0,033 0,0035 0,0024 0,073 0,2003 
INSA 29 25 56 1,1 25,52 0,017 0,0075 0,0003 0,009 0,0183 
Ifidesa Aristegui 29 20 46 1,2 16,56 0,051 0,009 0,0045 0,130 0,2068 
Janssen Cilag 27 26 30 1 18,18 0,054 0,0086 0,0064 0,174 0,1929 
ACERINOX 27 23 36 1,1 23,5 0,014 0,0034 0,0002 0,004 0,0055 
 
The graph in Figure 2, in turn, shows the structure of the network of top 50 firms 
only. This type of node-and-link schemes are used to highlight certain aspects of a 
network. In this case, the deliberate aim was to retrieve the relationships among the top 
50 firms. Such invasive action has obvious consequences. As the figure shows, only 32 
of the 50 companies initially forming the network appear in the graph, for the other 18 
were eliminated for want of connections. Another prominent feature is the presence of 
three institutions outside the top 50, whose intermediation between companies 
guarantees network stability. 
 
Figure 2. Schematic map of the network of top 50 firms 
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For graphic reasons, the node profiles were limited to three basic colours. The 
darkest identifies non-top 50 intermediaries. The lightest are pharmaceutical companies. 
The in-between shade represents all other engineering-materials-chemistry and 
biotechnology firms. The thickness of the lines representing the links is an indication of 
the number of joint studies conducted by the nodes in question. 
 
5. Discussion 
 
While accounting for only 4 % of the total, the sample of companies selected for this 
study produce nearly 50 % of the studies co-authored by companies, a clear indication 
of their relevance. 
Medicine, physiology and pharmacology are the three most productive areas of 
specialization. 
 
Table 9. Top 50 company profile and size 
 
Profile Firms % Firms  Size* % Firms 
Pharmacology 29 58  Large enterprises (LE) 64 
Biotechnology 4 8  Small and medium-sized enterprises (SMEs) 34 
Chemistry 3 6  Unknown 2 
Engineering 3 6  
Materials science 3 6  
Medicine 3 6  
Communications 2 4  
Nutrition 2 4  
Energy 1 2  
*http://ec.europa.eu/enterprise/enterprise_policy/sme_definition/index_en.htm 
 
The volume of studies in the areas of medicine and molecular biology is similar to 
the weight of these disciplines in Spanish scientific output (Moya-Anegón F et al., 
2008), and to the pattern found in most industrialized countries, according to the 
SCImago Journal and Country Rank (SJR, 2009). The values for physiology and 
pharmacology, by contrast, are higher on both counts. The preponderance of 
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pharmacological studies can be explained by the profile of the companies analyzed 
(Table 9). Moreover, the high productivity in biomedical areas confirms the sensitivity 
of such companies to knowledge transfer and their role as mediators between 
universities and the market (Audretsch DB and Stephan PE, 1996). 
The geographic distribution shows that over half of the top 50 firms’ papers are 
generated by Madrilenian companies, which account for 44 % of all the companies in 
the sub-set analyzed. From the standpoint of collaboration, however, while institutions 
in Madrid account for 61 % of the output, more Catalonian than Madrilenian institutions 
participate in joint projects. Valencian firms also make a substantial contribution, for 
while only 2 % of top 50 firms are located there, they account for more collaboration 
and production than the 6 % of organizations in the Basque Country, for instance. 
The overall analysis of the regional data corroborates the importance of geographic 
proximity in national collaboration. The findings for international collaboration likewise 
ratify the role of geographic proximity in the choice of partners. Nearly 90 % of the 
joint papers involve European partners and nine of the ten countries with the highest 
collaboration rates are in Western Europe. 
Nonetheless, in both national and international collaboration, a strong relationship 
can be observed between partnering region/country and scientific and research 
importance that transcends geographic barriers. In other words, the choice of partners 
may be due to geographic proximity, but objective data show that such relations are 
based less on geography than on partners’ importance and the expectations around the 
validity of joint results. By way of example, over 40 % of the joint papers were co-
authored with institutions in the United States, where links are not due to proximity. 
The choice of an English partner, for instance, would be due less to country proximity 
than to the fact that it ranked second in total output between 1996 and 2007 (SJR, 
2009). The same argument is applicable to Madrid and Catalonia as drivers of science in 
Spain (Chinchilla-Rodríguez Z, 2006), (Moya-Anegón F et al., 2008). 
By sectors, health system-related institutions are companies’ preferred partners, 
which is consistent with the profile of the companies analyzed and their area of 
specialization. While the volume of studies conducted with universities is not 
surprising, the number of such institutions collaboration with private enterprise is 
unexpectedly low, and even smaller than the number of non-top 50 participants. In this 
case, the choice of partners is clearly related to reputation, for companies ignore sectoral 
affinities when seeking collaboration. 
With regard to the network analysis findings, Spearman coefficient values (Table 10) 
were found for the comparisons of two bibliometric (number of documents and number 
of citations), three structural (degree, betweenness and clustering coefficient) and two 
hybrid (popularity and prestige indexes) indicators. 
 
Table 10. Spearman's rank correlation coefficient for simple and hybrid indicators 
 
Indicator Rank correlation 
Betweenness-popularity index 0,625 
Betweenness-prestige index 0,431 
Citations-popularity index 0,595 
Citations-prestige index 0,694 
Clustering coefficient-betweenness 0,666 
Clustering coefficient-citations 0,387 
Clustering coefficient-degree 0,835 
Clustering coefficient-ndoc 0,289 
Clustering coefficient-popularity index 0,754 
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Clustering coefficient-prestige index 0,698 
Degree-popularity index 0,659 
Degree-prestige index 0,545 
ndoc-popularity index 0,477 
ndoc-prestige index 0,401 
Popularity index-prestige index 0,888 
 
The resulting values show that the lowest correlations are found for the variables 
constituting the hybrid indicators (clustering coefficient-ndoc and clustering coefficient-
citations). Moreover, the correlation between ndoc and popularity index is scantly 
significant, statistically speaking. The dependence between citations and prestige index 
is higher. Moreover, the high correlation between the two hybrid indicators shows that 
in this case the most popular and most prestigious nodes largely concur. 
Lastly, even though grid mapping led to the elimination of some of the original 
nodes, it is an excellent tool for reducing complexity, for it shows the central node of 
the top 50 companies that have interconnections. Of particular relevance is the function 
of the three intermediary institutions that support the main structure, forming the 
backbone of inter-company relations. The University of Salamanca (USAL) partners 
with nutrition and pharmacology companies. Madrid’s Institute of Materials Science 
(ICCM) collaborates with engineering, energy and materials science companies, and the 
Institute of Biomedical Research of Barcelona (IDIBAPS) with pharmacology firms. 
Light coloured nodes, i.e., pharmacological companies, predominate in the top 50 
structural core. Companies with other business profiles are found in peripheral 
positions. Lilly, located at the centre of the diagram, participates in joint research with 
some of the most productive nodes in the sector, and also maintains links with the three 
non-top 50 intermediaries. 
 
6. Conclusions 
 
The study aimed to deliver empirical results based on quantitative data to gain insight 
into the role of private enterprise as an indispensable actor in scientific development and 
innovation. To this end, an analysis was conducted of the contribution made by Spanish 
business, focusing on the 50 most active companies in terms of internationally visible 
scientific output, from three perspectives. The first explored their involvement in the 
R&D system, measured in number of scientific papers published, and their distribution 
by subject area. The second consisted in a detailed review of their national, international 
and sectoral collaboration patterns. The third analyzed the resulting collaboration 
networks, their structural patterns and the identification of company prominence on the 
grounds of a systematic comparison of their research results and structural position. 
While private enterprise accounts for 30 % of the institutions participating in national 
scientific output, it authors only 3 % of the published papers, although 62 % of that 
production involves some manner of collaboration. This is a reflection of the fact that 
SMEs account for nearly all Spanish enterprise (99 %)  (Ministerio de Industria, 2009), 
and of the special social, political and economic features that characterize the Spanish 
private sector (Bayona C et al., 2001), (Segarra-Blasco A and Arauzo-Carod JM, 2008). 
In this regard, the findings show that output was low in 75 % of the collaborating 
Spanish firms, which produced a maximum of only three joint papers with international 
visibility in the period studied. It is hardly surprising, then, that most of the top 50 firms 
are large-scale companies, for such firms are traditionally better positioned to invest in 
R&D and consequently have a higher scientific output, confirming that large companies 
ensure collaboration success (Okamuro H, 2007). The relevant role of Spanish 
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pharmaceutical companies is closely related to these considerations. While sectoral 
production in other major areas of science is similar to absolute figures for the 
respective domestic industry, output in physiology and pharmacology is perceptibly 
higher. This confirms the pharmaceutical industry’s prominence in international 
scientific production in the pursuit of new knowledge (Calero C et al., 2007). 
The choice of national and international partners, while often concurring with 
institutions that are geographically close, is based on merit and scientific importance 
endorsed by the relevance of their research findings. This confirms that working with 
reputed partners contributes to the success of collaboration (Mora Valentín EM et al., 
2004). Internationally, the predominance of the U.S. is related to that country’s 
hegemony in biomedicine and pharmaceuticals (Miotti L and Sachwald F, 2003). In the 
domestic arena, collaboration with the rest of the institutional sectors is in line with the 
absolute values for Spanish output as a whole, although two aspects stand out: on the 
one hand, the strong tendency to collaborate with universities; and on the other, the 
participation of enterprise in its own output in terms of number of institutions but not of 
papers. The enterprise network reveals the importance of pharmaceutical companies, not 
only because of their predominance, but also because of their structural position and 
intense partnering. This shows that collaboration is more fluent among institutions with 
the same business profile. 
One of the core ideas of this study is the emphasis on the essential role of 
collaboration in improving scientific results, as borne out by the correlation between the 
clustering coefficient and the hybrid indicators. The findings also provide proof of the 
success of strategies for institutional collaboration. The low correlation coefficients 
between the different variables indicate that the intensity of a company’s collaboration 
is not contingent upon its output or visibility. Consequently, the predominance of an 
organization in a given indicator (production or visibility) is independent of its 
popularity or prestige index values. The foregoing shows that the application of hybrid 
indicators to institutional aggregates yields novel results not explored in preceding 
studies. 
Lastly, a number of factors mentioned in the introduction but not covered here may 
constitute the object of future study.  One might be the characteristics of national 
enterprise collaboration, based on the analysis of patents, research agreements and 
publicly funded projects. Such studies could focus on a specific business profile or 
geographic area (Malo S and Geuna A, 2000), (McMillan GS et al., 2000). Another area 
of interest is company motivation when seeking partners, based on an analysis of 
national and international collaboration, and whether such motivation affects the quality 
of the results or the intensity of collaboration. A third consideration would be the 
structural results of patent, research agreement and funded project networking, in 
particular as regards indicators both of centralization and for each of the participants. 
Finally, trends would have to be analyzed to ascertain collaboration structure and the 
changes taking place over time, for both bibliometric and structural indicators are 
dependent upon the size of the time window defined. 
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